Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

LEO Pharma invests in skin cancer detection mobile app firm

Willalso collaborate in digital health with Dutch company SkinVision

- PMLiVE

FDA approval keeps AZ on track with ambitious Brilinta plans

Receives additional indication for use in heart attack patients

- PMLiVE

India denies patent on Pfizer’s Xeljanz

Drug deemed not an invention because it is not more effective than original compound

- PMLiVE

Astellas launches cancer challenge social media campaign

Teamsup with USA Rugby and the Australian Rugby Union for #pass4prostate

Bristol-Myers Squibb (BMS) building

Opdivo plus Yervoy effective first-line in lung cancer

Study shows immuno-oncology agents work well together

- PMLiVE

Shire adds Sara Mathew to board of directors

Comes as firm aims to become global biotechnology leader

- PMLiVE

Boehringer Ingelheim appoints Andreas Neumann as HR lead

He will also join the company's board ofmanaging directors

- PMLiVE

Bringing about digital health change

Qualcomm's Rick Valencia on what the future could hold

- PMLiVE

Janssen’s myeloma drug wins FDA priority review

Monotherapy daratumumab to be reviewed within six months

- PMLiVE

mRNA – message received

Assessing the growing pharma interest in modified messenger RNA

- PMLiVE

EM Imaging appoints new chairman

John Jeans to bring firm to forefront of molecular imaging market

Biosimilars – the same, but different?

As more products reach European markets, US regulations are catching up with science

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links